tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nasdaq-100 Reshuffle: Who’s In, Who’s Out?
PremiumMarket NewsNasdaq-100 Reshuffle: Who’s In, Who’s Out?
5d ago
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
Premium
The Fly
Nasdaq adding Alnylam, Ferrovial, Insmed, Monolithic Power at open on 12/22
5d ago
Alnylam Pharmaceuticals: Hold Rating Due to Sales Projections Falling Short of Consensus
Premium
Ratings
Alnylam Pharmaceuticals: Hold Rating Due to Sales Projections Falling Short of Consensus
5d ago
Alnylam announces results from post hoc analyses of HELIOS-B Phase 3 study
PremiumThe FlyAlnylam announces results from post hoc analyses of HELIOS-B Phase 3 study
1M ago
Alnylam removed from US Conviction List at Goldman Sachs
Premium
The Fly
Alnylam removed from US Conviction List at Goldman Sachs
2M ago
Alnylam Pharmaceuticals Reports Strong TTR Growth Amid Challenges
Premium
Company Announcements
Alnylam Pharmaceuticals Reports Strong TTR Growth Amid Challenges
2M ago
Alnylam price target raised to $475 from $400 at Chardan
PremiumThe FlyAlnylam price target raised to $475 from $400 at Chardan
2M ago
Alnylam Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Alnylam Pharmaceuticals Reports Strong Q3 2025 Growth
2M ago
Alnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
Premium
Ratings
Alnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100